CB Insights named Atropos Health to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.
“From bringing clinical trials to underserved populations to developing new drugs and therapies, this year’s Digital Health 50 winners are transforming the future of healthcare,” said Alex Lennox-Miller, CB Insights’ Lead Healthcare Analyst. “Generative AI is continuing to gain traction in healthcare, with over thirty companies in this year’s cohort offering AI-augmented solutions. We are excited to follow the meaningful impact, industry-leading innovations, and continued success of this year’s winners.”
“I am thrilled for the Atropos Health Team and its users and customers to receive this recognition,” said Co-Founder and CEO Dr. Brigham Hyde. “We are committed to providing evidence-based insights in order to drive better patient outcomes, accelerate drug discovery, and ultimately save healthcare and life science organizations significant time and expenses.”
The 50 winners were selected from a pool of over 10K companies, including applicants and nominees. They were chosen based on several factors, including CB Insights datasets — covering R&D activity, Mosaic scores, business relationships, software buyer transcripts, investor profiles, news sentiment analysis, competitive landscape, and team strength — along with criteria such as tech novelty, market potential, and impact on the industry.
Atropos Health is used by clinicians, researchers, physicians, and drug developers to close the global evidence gap while accelerating clinical trial and decision-making timelines. The company’s products include Geneva OS™(Generative Evidence Acceleration Operating System) and the ChatRWD™ (Real World Data) application, the first Generative AI application incorporating direct Chat-to-Database capability.
These offerings enable non technical users to generate publication grade Observational Research studies leveraging deidentified patient level real world data from the Atropos Evidence Network in a matter of minutes, saving organizations valuable time, money, and staffing resources. Geneva OS and ChatRWD work alongside Atropos’ evidence solutions – the Green Button Informatics Consult Service, Atropos Evidence Network, and the Atropos Evidence Library.
SOURCE: BusinessWire
